0000899243-23-016073.txt : 20230620
0000899243-23-016073.hdr.sgml : 20230620
20230620205246
ACCESSION NUMBER: 0000899243-23-016073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALTMAN MICHAEL SETH
CENTRAL INDEX KEY: 0001746738
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39434
FILM NUMBER: 231027184
MAIL ADDRESS:
STREET 1: C/O PERCEPTIVE ADVISORS
STREET 2: 51 ASTOR PLACE, 10TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 981541723
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-15
0
0001808805
Nautilus Biotechnology, Inc.
NAUT
0001746738
ALTMAN MICHAEL SETH
51 ASTOR PLACE, 10TH FLOOR
NEW YORK
NY
10003
1
0
0
0
0
Stock Option (Right to Buy)
3.97
2023-06-15
4
A
0
45000
0.00
A
2033-06-15
Common Stock
45000
45000
D
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date.
/s/ Samuel M. Cohn, Attorney-in-Fact
2023-06-20